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114a Sunday, February 16, 2014ES-derived cardiomyocytes to identify specific perturbations in the Ca2þ signal
‘fingerprint’ evoked by a panel of CV-active drugs (1nM to 100mM). We calcu-
lated four indices that describe the spatial and temporal organisation of drug-
evoked Ca2þ cycling: 1) inter-transient noise (ITN), the amplitude variability
of Ca2þ signals occurring between Ca2þ transients; 2) peak regularity index
(PRI), a statistical assessment of Ca2þ transient peak-to-peak variability; 3)
height regularity index (HRI), the amplitude heterogeneity between successive
Ca2þ transients and 4) synchrony- the extent of synchronization of Ca2þ tran-
sients across the syncytia. These four parameters were integrated, together
with an assessment of cellular contractility, into a single non-biased safety
score. In operator-blinded analyses, the rank order of drug hazard was
confirmed as astemizole > flecainide > cisapride = sotalol > thioridazine >
valdecoxib >> nadolol = control. This assessment is remarkably similar to
the established hazard profile of these drugs. Our data support the utility of
this mechanistically agnostic framework for the rapid and discriminatory
evaluation of CV drug toxicity.
596-Pos Board B351
A Novel Fluorescent Epac-Agonist Reveals Epac1 and Epac2 Subcellular
Localization in Cardiomyocytes
Laetitia Pereira1, Jeffrey Erickson1, Ju Chen2, Donald M. Bers1.
1Pharmacology, UC Davis, Davis, CA, USA, 2Medicine, UC San Diego,
La Jolla, CA, USA.
Epac (Exchange proteins directly activated by cAMP) exist in two isoforms,
Epac1 and Epac2. In cardiomyocytes, evidence is building that Epac2 medi-
ates CaMKII and ryanodine receptor related arrhythmia whereas Epac1 over-
expression leads to cardiac hypertrophy. This suggests potential subcellular
localization differences for Epac1 and 2, but localization information in
myocytes has been limited by antibody specificity. Here, we used a novel
fluorescent cAMP-derivate Epac agonist 8-[Pharos-575]-2’-O-Me-cAMP
(F-O-Me-cAMP) to identify Epac1 and Epac2 cardiac localization. F-O-
Me-cAMP exhibits peak excitation at 543 nm and emission at 610 nm and
increases several-fold when bound to Epac. Its Epac specificity was verified
in double Epac1/Epac2 knockout mouse myocytes (DKO), and by competition
with the non-fluorescent Epac agonist, 8-CPT (Fluorescence= 1,6955162 for
F-O-Me-cAMP (n=13) vs. 394541 with 100 mM 8-CPT (n=20) and 439516
in DKO (n=52)). The apparent affinity of F-O-Me-cAMP (Kd) for Epac was
9.650.7 mM (n=14). F-O-Me-cAMP binding to PKA (a known cAMP target)
is excluded because of the DKO results above and its lack of effect on PKA
activity (assessed by a PKA-FRET-reporter) and a lack of effect of 100 mM
Rp-cAMP (a PKA specific activator) on F-O-Me-cAMP signals in cells.
Binding of 10 mM F-O-Me-cAMP in intact cells rose to a maximum with
t=30 min. Localization of F-O-Me-cAMP binding in Epac1-KO mice (i.e.
Epac2 location) was prominently T-tubular (tracking Di-8-ANEPPS), whereas
Epac1 distribution (in Epac2-KO cells) was non-striated and concentrated
around the nucleus. In conclusion, F-O-Me-cAMP is a valuable fluorescent
Epac-specific agonist. We conclude that Epac2 is T-tubular whereas Epac1
is more nuclear, which parallels their effects on Ca sparks and nuclear
signaling, respectively.
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The fraction of the sarcoplasmic reticulum (SR) Ca2þ content released at a
twitch (fractional release, FR) in cardiomyocytes is regulated by the L-type
Ca2þ current (ICa,L) and the SR Ca2þ content ([Ca2þ]SR). In the experimental
model of the functionally isolated SR (FISRM), cardiomyocytes are perfused
with Naþ, Ca2þ-free solution, which makes the cells unexcitable and thermo-
dynamically inhibits the sarcolemmal Naþ/Ca2þ exchanger. Intracellular free
Ca2þ concentration ([Ca2þ]i) was measured with fluo-3 and Ca2þ transients
due to SR release were evoked by 100 ms-long caffeine pulses. FISRM was
used to study the intrinsic relationship between FR and [Ca2þ]SR in the
absence of ICa,L, the physiological trigger for SR Ca2þ release. After SR
depletion by prolonged caffeine application, 1-20 electrical stimuli were
applied to attain different [Ca2þ]SR (from 55.3510.0 to 123.0510.3 mM).
The variation in total [Ca2þ] (D[Ca2þ]T) during transients was estimated
from [Ca2þ]i and Ca2þ buffering parameters. FR (D[Ca2þ]T/[Ca2þ]SR)
showed a non-linear relationship with [Ca2þ]SR (from 5.455.4 to
82.857.2%, p< 0.05), as previously observed when SR Ca2þ release was trig-
gered by ICa,L. This behavior was reproduced with a mathematical model of
FISRM, after inclusion of intra-SR and cytosolic Ca2þ buffers, which resulted
in more realistic simulations. In addition, FISRM was used to study the inhib-itory effect of tetracaine on FR. The tetracaine concentration that caused 50%
inhibition of FR (IC50) was 58.955.7 mM. The FISRM may be a useful
experimental model to investigate in intact cells the selective effects on SR
Ca2þ release of drugs that also affect sarcolemmal currents, such as tetracaine.
Support: CNPq.
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To probe the micro-domains of Ca2þ-signaling, we constructed a probe,
calstabi-cam, targeted to cardiac ryanodine receptors (RyR2) by FKBP12.6
(calstabin 2) incorporating calmodulin and EYFP as Ca2þ-sensor. 48-72h after
infection of cultured rat neonatal cardiomyocytes (rNCM), global measure-
ments of calstabi-cam fluorescence were accompanied by simultaneous
recordings of Ca2þ channel (ICa) and Na
þ/Ca2þ-exchanger (INCX) and
compared to measurements of fluo-4 Ca-transients. rNCMs continued sponta-
neous beating after dialysis with Csþ-based internal solutions (0.1-0.2mM
EGTA at 50mV) as they generated calstabi-cam fluorescence signals that
coincided with INCX oscillations, like those measured by fluo-4 that were
blocked by 10mM ryanodine. Activation of ICa (~5pA/pF) triggered slowly
relaxing Ca-transients of calstabi-cam fluorescence (DF/F0 = 0.11; n=14).
Similarly, short caffeine pulses also activated long lasting calstabi-cam signals
(-DF/F0=0.1550.012; n=28) accompanied by INCX (1.5750.13pA/pF; n=28).
Calstabi-cam signals activated by rapid Naþ withdrawal was significantly
delayed (~230ms) compared to those triggered by ICa (~13ms) or caffeine
(~35ms). Similar results were found in feline adult cardiac myocytes where
1mM Isoproterenol increased ICa significantly without enhancing the associ-
ated calstabi-cam transients. These results suggest that the new probe re-
sponds more effectively to Ca2þ that is released into dyadic clefts by RyR2
than by sarcolemmal Ca2þ influx via Na/Ca exchanger. The extremely slow
decay kinetics of Calstabi-cam signal is consistent with the notion that
[Ca2þ] in the dyadic cleft may rise to much higher values than those of
cytosol.
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Diverse interactions between Ca2þ and reactive oxygen species (ROS) signal-
ling are thought to exist and be of both physiological and pathophysiological
relevance. We hypothesized that ROS and Ca2þ interact locally at the ER-
mitochondrial interface to induce mitochondrial Ca2þ-overload and subse-
quent permeability transition. To test the relationship between ROS and
Ca2þ, we used genetically-encoded tools to selectively generate and measure
ROS at confined locations within HepG2 and MEF cells. Using Killer Red
(KR) targeted to the ER-mitochondrial interface or nucleus, we selectively
controled the oxidation of these compartments with illumination. When
KR was targetted to the ER-Mitochondrial interface, illumination caused
a >3-fold increase in cytoplasmic Ca2þ response to a low-dose IP3-linked
agonist as measured with fura 2, whereas illumination of the KR targeted
to the nucleus was ineffective. These data demonstrate that ROS generated
at the ER-mitochondrial interface are capable of sensitizing Ca2þ release,
whereas more distant ROS was not. To test if (patho)physiological conditioins
could oxidise the ER-mitochondrial interface in the same way, we utilized the
genetically-encoded ratiometric sensor HyPer and the redox de-sensitized
derivative SypHer to control for non-specific changes. These probes, targeted
to the ER-mitochondrial interface or nucleus, are positioned to assess redox
changes at a local level. When permeabilized MEF cells were subject to mito-
chondrial Ca2þ overload, a cyclosporine A-sensitive decrese in mitochondrial
membrane potential, consistent with permeability transition, was observed.
This was accompanied by a pronounced burst of H2O2 at the ER-
mitochondrial interface but not the nucleus. These data demonstrate that the
ER-mitocondrial interface may host a local redox microdomain and that
ROS generated at locations immediately apposed to Ca2þ-transport proteins,
such as the IP3 receptor, sensitize Ca2þ release whereas distant ROS did
not. These observations underline the critical role of spatial organization in
ROS-Ca2þ crosstalk in mitochondrial signalling.
